Back to Search Start Over

Resveratrol in Cancer Patients: From Bench to Bedside.

Authors :
Berretta, Massimiliano
Bignucolo, Alessia
Di Francia, Raffaele
Comello, Francesco
Facchini, Gaetano
Ceccarelli, Manuela
Iaffaioli, Rosario Vincenzo
Quagliariello, Vincenzo
Maurea, Nicola
Source :
International Journal of Molecular Sciences. 4/15/2020, Vol. 21 Issue 8, p2945-2945. 1p. 7 Diagrams, 2 Charts.
Publication Year :
2020

Abstract

Resveratrol (3,5,4′-trihydroxystilbene) is a natural phytoalexin that accumulates in several vegetables and fruits like nuts, grapes, apples, red fruits, black olives, capers, red rice as well as red wines. Being both an extremely reactive molecule and capable to interact with cytoplasmic and nuclear proteins in human cells, resveratrol has been studied over the years as complementary and alternative medicine (CAM) for the therapy of cancer, metabolic and cardiovascular diseases like myocardial ischemia, myocarditis, cardiac hypertrophy and heart failure. This review will describe the main biological targets, cardiovascular outcomes, physico-chemical and pharmacokinetic properties of resveratrol in preclinical and clinical models implementing its potential use in cancer patients. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
16616596
Volume :
21
Issue :
8
Database :
Academic Search Index
Journal :
International Journal of Molecular Sciences
Publication Type :
Academic Journal
Accession number :
142950943
Full Text :
https://doi.org/10.3390/ijms21082945